Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junichi Nishimura

Showing results (161-170 of 258) with videos related to

Pageof 26
Sort By:
International Journal of Oncology|May 28, 2013
Concurrent expression of C4.4A and Tenascin-C in tumor cells relates to poor prognosis of esophageal squamous cell carcinomaMasahisa Ohtsuka, Hirofumi Yamamoto, Ryota Oshiro, et al.
Scientific Reports|November 9, 2016
Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal CancerHugh Colvin, Naohiro Nishida, Masamitsu Konno, et al.
Oncology Reports|October 2, 2014
Circulating miR-199a-3p as a novel serum biomarker for colorectal cancerRyoji Nonaka, Junichi Nishimura, Yoshinori Kagawa, et al.
International Surgery|July 25, 2014
Short-term outcomes of simultaneous laparoscopic colectomy and hepatectomy for primary colorectal cancer with synchronous liver metastasesAkira Inoue, Mamoru Uemura, Hirofumi Yamamoto, et al.
Journal of the Anus, Rectum and Colon|August 4, 2020
Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal CancerJunichi Nishimura, Junichi Hasegawa, Shingo Noura, et al.
International Journal of Oncology|March 4, 2014
SCGB2A1 is a novel prognostic marker for colorectal cancer associated with chemoresistance and radioresistanceKoji Munakata, Mamoru Uemura, Ichiro Takemasa, et al.
Molecular and Clinical Oncology|July 19, 2019
Erratum: A novel prognostic prediction model for recurrence in patients with stage II colon cancer after curative resectionKazuhiro Saso, Norikatsu Myoshi, Shiki Fujino, et al.
Annals of Gastroenterological Surgery|January 31, 2019
Comparison of the modified Collard and hand-sewn anastomosis for cervical esophagogastric anastomosis after esophagectomy in esophageal cancer patients: A propensity score-matched analysisKeijiro Sugimura, Hiroshi Miyata, Tomoyuki Matsunaga, et al.
Oncology Letters|June 12, 2025
Clinical and prognostic characteristics of metastatic colorectal cancer with minor <i>RAS</i> mutationsYoshiki Kojitani, Daisuke Sakai, Takatsugu Ogata, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2018
Heme ameliorates dextran sodium sulfate-induced colitis through providing intestinal macrophages with noninflammatory profilesHisako Kayama, Masako Kohyama, Daisuke Okuzaki, et al.
Pageof 26

Showing results (161-170 of 258) with videos related to

Sort By:
Pageof 26
International Journal of Oncology|May 28, 2013
Concurrent expression of C4.4A and Tenascin-C in tumor cells relates to poor prognosis of esophageal squamous cell carcinomaMasahisa Ohtsuka, Hirofumi Yamamoto, Ryota Oshiro, et al.
Scientific Reports|November 9, 2016
Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal CancerHugh Colvin, Naohiro Nishida, Masamitsu Konno, et al.
Oncology Reports|October 2, 2014
Circulating miR-199a-3p as a novel serum biomarker for colorectal cancerRyoji Nonaka, Junichi Nishimura, Yoshinori Kagawa, et al.
International Surgery|July 25, 2014
Short-term outcomes of simultaneous laparoscopic colectomy and hepatectomy for primary colorectal cancer with synchronous liver metastasesAkira Inoue, Mamoru Uemura, Hirofumi Yamamoto, et al.
Journal of the Anus, Rectum and Colon|August 4, 2020
Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal CancerJunichi Nishimura, Junichi Hasegawa, Shingo Noura, et al.
International Journal of Oncology|March 4, 2014
SCGB2A1 is a novel prognostic marker for colorectal cancer associated with chemoresistance and radioresistanceKoji Munakata, Mamoru Uemura, Ichiro Takemasa, et al.
Molecular and Clinical Oncology|July 19, 2019
Erratum: A novel prognostic prediction model for recurrence in patients with stage II colon cancer after curative resectionKazuhiro Saso, Norikatsu Myoshi, Shiki Fujino, et al.
Annals of Gastroenterological Surgery|January 31, 2019
Comparison of the modified Collard and hand-sewn anastomosis for cervical esophagogastric anastomosis after esophagectomy in esophageal cancer patients: A propensity score-matched analysisKeijiro Sugimura, Hiroshi Miyata, Tomoyuki Matsunaga, et al.
Oncology Letters|June 12, 2025
Clinical and prognostic characteristics of metastatic colorectal cancer with minor <i>RAS</i> mutationsYoshiki Kojitani, Daisuke Sakai, Takatsugu Ogata, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2018
Heme ameliorates dextran sodium sulfate-induced colitis through providing intestinal macrophages with noninflammatory profilesHisako Kayama, Masako Kohyama, Daisuke Okuzaki, et al.
Pageof 26